Acquisitions, Mergers & PartnershipsBiomaterialsBioprinting

Regemat3D distributing Biogelx bioprinting inks

The companies have formed a strategic alliance aimed at bringing complete bioprinting solutions to research institutions

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Spanish bioprinter manufacturer Regemat3D has entered into an R&D and distribution partnership with Biogelx, a Scotland-based developer of synthetic bioinks. Through the collaboration, Regemat will add Biogelx’s synthetic bioink products to its distribution portfolio and the companies will aim to offer complete bioprinting solutions to researchers across the world.

Since 2011, Regemat3D has provided custom bioprinting solutions to the research market, including the REGEMAT 3D V1 bioprinter. The company has also played an important role in pushing bioprinting research ahead, working with partners around the globe to develop clinical and pre-clinical models for skin regeneration, living tissues and other applications.

In addition to distributing its materials, Regemat3D will work with Biogelx in an R&D capacity to develop a new skin model leveraging the former’s bioprinting technology and the latter’s synthetic biomaterials.

Regemat3D Biogelx partnership

“We are excited to see future tissue models using Biogelx-INKs,” said Sandy Bulloch, Director of Strategic Alliances at Biogelx. “We believe that this strategic partnership will expand the distribution of our novel peptide-based bioink products to new and existing customers worldwide and provide Regemat3D with an extended platform to provide their customers a robust synthetic bioink for use with their very successful range of bioprinters.”

Biogelx was formed as a spinout of the University of Strathclyde. In a short time, it has made a mark on the bioprinting market by introducing synthetic bioprinting materials based on its self-assembling peptide hydrogel technology. Compared to naturally derived bioinks, the synthetic ones can be tuned with more accuracy and have higher repeatability. When printed, the biomimetic inks can support cell growth, signalling and proliferation for various applications.

“Regemat 3D is always seeking out the best 3D bioprinting technologies solutions that the researchers need. We do believe that this new collaboration with Biogelx will open a new opportunity to offer something new and exciting for researchers to enjoy a true combination of consistency, reproducibility and value for money. The two brands together offer something new and exciting for researchers to enjoy a true combination of consistency, reproducibility and value for money. We’re thrilled to be working with Biogelx on this exciting opportunity.” – Said Manuel Figueruela, Regemat3D CEO

Research 2022
Polymer AM Market Opportunities and Trends

741 unique polymer AM companies individually surveyed and studied. Core polymer AM market generated $4.6 billion...

Tess Boissonneault

Tess Boissonneault is a Montreal-based content writer and editor with five years of experience covering the additive manufacturing world. She has a particular interest in amplifying the voices of women working within the industry and is an avid follower of the ever-evolving AM sector. Tess holds a master's degree in Media Studies from the University of Amsterdam.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*